CompaniesPX' Therapeutics

PX' Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

72

By Phase

PHASE1: 2

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
Today
NCT01509144
NCT01827397
Hover over trial bars to see details

Recent Trials

NCT01827397Lead Sponsor
Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine
PHASE1Completed
24 participants
Started: Apr 30, 2013 · Completed: Feb 28, 2014
NCT01509144Lead Sponsor
EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine
PHASE1Completed
48 participants
Started: Jan 31, 2012 · Completed: Oct 31, 2013
Related Companies
Promise Proteomics
acquired